Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Platelet-rich plasma therapy shows promise for hair regrowth in alopecia patients.

The document concludes that advancements in hair restoration surgery have led to more natural results and patient satisfaction, with hope for future improvements in treatment.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Low iron levels are strongly linked to chronic hair loss in women.

Scalp needle mesotherapy can effectively treat hair loss and improve hair growth.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Azathioprine may be an effective treatment for severe hair loss.

Low-power laser therapy is an effective, side-effect-free treatment that speeds up hair regrowth and crural ulcer healing.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Dermatologists in Western Rajasthan often prescribe doxepin for elderly patients with skin and mental health issues.

SIG-1451 could be a promising new treatment for atopic dermatitis.